Affected provisions

1. 2: Interpretation
   The definition of consent has been updated to include consent by verification for the sale, distribution, and advertising of new medicines
2. 9: Medicines Classification Committee
   The Medicines Classification Committee's composition, membership, and quorum requirements have been revised
3. 20: Restrictions on sale or supply of new medicines
   The definition of consent has been updated to include consent by verification for the sale, distribution, and advertising of new medicines
4. 21: Applications for Minister's consent
   The application process for the Minister's consent has been revised, including changes to required particulars and timeframes
5. 22: Procedure in respect of applications for Minister's consent
   The application process for the Minister's consent has been revised, including changes to required particulars and timeframes
6. 23A: Interpretation
   The definition of consent has been updated to include consent by verification for the sale, distribution, and advertising of new medicines; The protection of confidential supporting information has been updated to include applications for consent by verification
7. 23: Minister may give provisional consent
   The application process for the Minister's consent has been revised, including changes to required particulars and timeframes
8. 23C: Circumstances where protection under section 23B or 23BA does not apply
   The protection of confidential supporting information has been updated to include applications for consent by verification
9. 24: Distribution of changed medicines restricted
   Timeframes for restricting the distribution of changed medicines and for requiring further information have been amended
10. 29: Exemption for medicine required by specified practitioners
    Exemptions for medicine required by specified practitioners and for clinical trials have been broadened and updated
11. 30: Exemption for clinical trial
    Exemptions for medicine required by specified practitioners and for clinical trials have been broadened and updated
12. 35: Revocation and suspension of consents
    The Minister's power to revoke or suspend consents has been amended to include section 22D and to use inclusive language
13. 42C: Restriction on authorised prescribers and delegated prescribers holding interest in pharmacies
    Section 42C has been repealed, and the right of appeal to the High Court has been updated to include section 22D
14. 89: Right of appeal to High Court
    Section 42C has been repealed, and the right of appeal to the High Court has been updated to include section 22D